Below are all of our recent announcements and news feed.
(OTTAWA, March 22, 2023) Genomadix , based in Ottawa, Canada, announced today the US Food and Drug Administration (FDA) granted 510(k) clearance permitting marketing of its “Genomadix CubeTM CYP2C19 System” …
22/03/23
Read GENOMADIX ANNOUNCES FDA CLEARANCE TO MARKET THE GENOMADIX CUBE CYP2C19 SYSTEMOTTAWA, ON, Aug. 29, 2022 /CNW/ – Genomadix today announced it has entered into a know-how license agreement and stock purchase agreement with Mayo Clinic to advance its point of care molecular …
29/08/22
Read Genomadix Inc. Announces Know-How License Agreement with Mayo ClinicGENOMADIX ANNOUNCES SECURING TWO YEARS OF FUNDING Diagnostic Provider Poised for Significant Growth Upon Market Authorization (OTTAWA, July 18, 2022) Genomadix , based in Ottawa, Canada, today announced that a …
20/07/22
Read GENOMADIX ANNOUNCES SECURING TWO YEARS OF FUNDINGOTTAWA, September 17th, 2021 – Spartan Bioscience Inc. (Spartan) announces today that its primary assets have been acquired by Genomadix Inc. (Genomadix) a new company formed to carry on Spartan’s mission. …
21/09/21
Read Spartan Bioscience Now Genomadix Inc.Looking For a Press Kit or an Interview?